3-heptadecylcatechol profile

3-heptadecylcatechol : Catechol substituted at position 3 with a heptadecyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID Source	ID
PubMed CID	119222
CHEBI ID	59112
SCHEMBL ID	1614566
MeSH ID	M0107510

Synonyms (18)

Synonym
3-heptadecylbenzene-1,2-diol
3-heptadecylpyrocatechol
3-heptadecylcatechol
3-heptadecyl-1,2-benzenediol
3-n-heptadecylpyrocatechol
CHEBI:59112 ,
3-n-heptadecylcatechol
5862-27-1
HDC ,
1,2-benzenediol, 3-heptadecyl-
29r0483xlz ,
unii-29r0483xlz
EPITOPE ID:122678
(17:0)-urushiol [mi]
heptadecylcatechol
SCHEMBL1614566
DTXSID60207331
Q27126465

Research Excerpts

Dosage Studied

Excerpt	Relevance	Reference
" High doses produced a greater degree of hyposensitization regardless of the dosage schedule used."	( Immunologic studies of poisonous Anacardiaceae: oral desensitization to poison ivy and oak urushiols in guinea pigs. ElSohly, MA; Murphy, JC; Watson, ES, 1983)	0.27

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

Class	Description
catechols	Any compound containing an o-diphenol component.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	5 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.50 (24.57)
Research Supply Index	1.95 (2.92)
Research Growth Index	4.45 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	1 (20.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	4 (80.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
3-pentadecacatechol 3-pentadecacatechol: structure. 3-pentadecylcatechol : Catechol substituted at position 3 with a pentadecyl group.	4.04	3	1	catechols	allergen
urushiol [no description available]	2.65	3	0

Condition	Relationship Strength	Studies	Trials
Contact Dermatitis [description not available]	2.65	3	0
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.	1.96	1	0
Delayed Hypersensitivity [description not available]	1.96	1	0
Dermatitis, Poison Ivy [description not available]	4.04	3	1
Dermatitis, Contact A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.	2.65	3	0

3-heptadecylcatechol

Description